Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2010
Total Assets: $64.7M
Liabilities Breakdown FY2010
Total Liabilities: $76.1M
Asset Breakdown
Total Assets: $64.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $35.9M | 55.5% |
| Accounts Receivable | $7.0M | 10.8% |
| Inventory | $1.2M | 1.8% |
| Property, Plant & Equipment | $17.5M | 27.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.2M | 4.9% |
Liabilities Breakdown
Total Liabilities: $76.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.3M | 8.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $69.8M | 91.8% |